{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:38:04Z","timestamp":1792546684450,"version":"4.5.0"},"reference-count":106,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1K01HL131333-01"],"award-info":[{"award-number":["1K01HL131333-01"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.01851","type":"journal-article","created":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T05:27:41Z","timestamp":1513920461000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":55,"title":["Beyond Antibodies: B Cells and the OPG\/RANK-RANKL Pathway in Health, Non-HIV Disease and HIV-Induced Bone Loss"],"prefix":"10.3389","volume":"8","author":[{"given":"Kehmia","family":"Titanji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,12,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1210\/jc.2008-0828","article-title":"Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system","volume":"93","author":"Triant","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e17217","DOI":"10.1371\/journal.pone.0017217","article-title":"Increased risk of fragility fractures among HIV infected compared to uninfected male veterans","volume":"6","author":"Womack","year":"2011","journal-title":"PLoS One"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1093\/cid\/ciq242","article-title":"Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006","volume":"52","author":"Young","year":"2011","journal-title":"Clin Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1210\/jc.2003-031506","article-title":"Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia","volume":"89","author":"Brown","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1097\/00002030-200309050-00010","article-title":"Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy","volume":"17","author":"Bruera","year":"2003","journal-title":"AIDS"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s00198-007-0428-7","article-title":"Fragility fractures and bone mineral density in HIV positive women: a case-control population-based study","volume":"18","author":"Prior","year":"2007","journal-title":"Osteoporos Int"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1097\/QAD.0b013e32833a3946","article-title":"Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals","volume":"24","author":"van Sighem","year":"2010","journal-title":"AIDS"},{"key":"B8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/COH.0000000000000028","article-title":"The effects of untreated and treated HIV infection on bone disease","volume":"9","author":"Cotter","year":"2014","journal-title":"Curr Opin HIV AIDS"},{"key":"B9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11904-014-0216-x","article-title":"Bone alterations associated with HIV","volume":"11","author":"Warriner","year":"2014","journal-title":"Curr HIV\/AIDS Rep"},{"key":"B10","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/joim.12520","article-title":"HIV infection and bone disease","volume":"280","author":"Compston","year":"2016","journal-title":"J Intern Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/phar.1257","article-title":"Bone health and human immunodeficiency virus infection","volume":"33","author":"Schafer","year":"2013","journal-title":"Pharmacotherapy"},{"key":"B12","first-page":"385","article-title":"HIV and bone metabolism","volume":"11","author":"Ofotokun","year":"2011","journal-title":"Discov Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e0118531","DOI":"10.1371\/journal.pone.0118531","article-title":"Aging with HIV vs. HIV seroconversion at older age: a diverse population with distinct comorbidity profiles","volume":"10","author":"Guaraldi","year":"2015","journal-title":"PLoS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nrrheum.2009.217","article-title":"Osteoimmunology and the effects of the immune system on bone","volume":"5","author":"Takayanagi","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nrendo.2016.91","article-title":"Physiological and pathophysiological bone turnover \u2013 role of the immune system","volume":"12","author":"Weitzmann","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11904-011-0099-z","article-title":"HIV: inflammation and bone","volume":"9","author":"Ofotokun","year":"2012","journal-title":"Curr HIV\/AIDS Rep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/35046196","article-title":"Bone versus immune system","volume":"408","author":"Arron","year":"2000","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1016-8478(23)12997-9","article-title":"Osteoimmunology: interactions of the immune and skeletal systems","volume":"17","author":"Rho","year":"2004","journal-title":"Mol Cells"},{"key":"B19","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/35005552","article-title":"Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand","volume":"402","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/rheumatology\/keg447","article-title":"T-cell involvement in osteoclast biology: implications for rheumatoid bone erosion","volume":"43","author":"O\u2019Gradaigh","year":"2004","journal-title":"Rheumatology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1177\/10454411010120020301","article-title":"Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption","volume":"12","author":"Taubman","year":"2001","journal-title":"Crit Rev Oral Biol Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1034\/j.1600-0765.2003.00615.x","article-title":"Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis","volume":"38","author":"Crotti","year":"2003","journal-title":"J Periodontal Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.bone.2010.06.011","article-title":"How B cells influence bone biology in health and disease","volume":"47","author":"Horowitz","year":"2010","journal-title":"Bone"},{"key":"B24","doi-asserted-by":"publisher","first-page":"987","DOI":"10.2353\/ajpath.2006.060180","article-title":"B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease","volume":"169","author":"Kawai","year":"2006","journal-title":"Am J Pathol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1182\/blood-2006-07-037994","article-title":"B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo","volume":"109","author":"Li","year":"2007","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e1004497","DOI":"10.1371\/journal.ppat.1004497","article-title":"Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection","volume":"10","author":"Titanji","year":"2014","journal-title":"PLoS Pathog"},{"key":"B27","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2174\/1568010054022015","article-title":"Osteoblasts and osteoclasts in bone remodeling and inflammation","volume":"4","author":"Tanaka","year":"2005","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"B28","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nrg1122","article-title":"Genetic regulation of osteoclast development and function","volume":"4","author":"Teitelbaum","year":"2003","journal-title":"Nat Rev Genet"},{"key":"B29","doi-asserted-by":"publisher","first-page":"125705","DOI":"10.1155\/2013\/125705","article-title":"The role of inflammatory cytokines, the RANKL\/OPG axis, and the immunoskeletal interface in physiological bone turnover and osteoporosis","volume":"2013","author":"Weitzmann","year":"2013","journal-title":"Scientifica (Cairo)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000431091","article-title":"Immunology of osteoporosis: a mini-review","volume":"62","author":"Pietschmann","year":"2016","journal-title":"Gerontology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nri1780","article-title":"Microenvironmental niches in the bone marrow required for B-cell development","volume":"6","author":"Nagasawa","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1146\/annurev.immunol.19.1.595","article-title":"B cell development pathways","volume":"19","author":"Hardy","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"16976","DOI":"10.1073\/pnas.0802898105","article-title":"Osteoblastic regulation of B lymphopoiesis is mediated by Gs{alpha}-dependent signaling pathways","volume":"105","author":"Wu","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B34","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/333571a0","article-title":"Stimulation of B-cell progenitors by cloned murine interleukin-7","volume":"333","author":"Namen","year":"1988","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1210\/endo.139.3.5837","article-title":"Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG\/OCIF inhibits osteoclastogenesis in vitro","volume":"139","author":"Yasuda","year":"1998","journal-title":"Endocrinology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.1210\/endo.142.12.8536","article-title":"Minireview: the OPG\/RANKL\/RANK system","volume":"142","author":"Khosla","year":"2001","journal-title":"Endocrinology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.cytogfr.2004.06.004","article-title":"The molecular triad OPG\/RANK\/RANKL: involvement in the orchestration of pathophysiological bone remodeling","volume":"15","author":"Theoleyre","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"B39","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.4049\/jimmunol.161.11.6113","article-title":"OPG\/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40","volume":"161","author":"Yun","year":"1998","journal-title":"J Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1359\/jbmr.2000.15.1.2","article-title":"The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption","volume":"15","author":"Hofbauer","year":"2000","journal-title":"J Bone Miner Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/jcb.10436","article-title":"Inflammatory T cells rapidly induce differentiation of human bone marrow stromal cells into mature osteoblasts","volume":"88","author":"Rifas","year":"2003","journal-title":"J Cell Biochem"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","article-title":"Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification","volume":"12","author":"Bucay","year":"1998","journal-title":"Genes Dev"},{"key":"B43","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1006\/bbrc.1998.8697","article-title":"Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor\/osteoprotegerin","volume":"247","author":"Mizuno","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.4049\/jimmunol.166.3.1482","article-title":"Osteoprotegerin, a crucial regulator of bone metabolism, also regulates B cell development and function","volume":"166","author":"Yun","year":"2001","journal-title":"J Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"25190","DOI":"10.1074\/jbc.272.40.25190","article-title":"TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells","volume":"272","author":"Wong","year":"1997","journal-title":"J Biol Chem"},{"key":"B46","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrd3705","article-title":"Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab","volume":"11","author":"Lacey","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"B47","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"B48","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/36593","article-title":"A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function","volume":"390","author":"Anderson","year":"1997","journal-title":"Nature"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1101\/gad.13.18.2412","article-title":"RANK is essential for osteoclast and lymph node development","volume":"13","author":"Dougall","year":"1999","journal-title":"Genes Dev"},{"key":"B50","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1073\/pnas.96.7.3540","article-title":"Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand","volume":"96","author":"Hsu","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.4049\/jimmunol.1102063","article-title":"Development and function of murine B cells lacking RANK","volume":"188","author":"Perlot","year":"2012","journal-title":"J Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ajhg.2008.06.015","article-title":"Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations","volume":"83","author":"Guerrini","year":"2008","journal-title":"Am J Hum Genet"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1056\/NEJM200211143472015","article-title":"Osteoprotegerin deficiency and juvenile Paget\u2019s disease","volume":"347","author":"Hofbauer","year":"2002","journal-title":"N Engl J Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1172\/JCI9133","article-title":"Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget\u2019s disease of bone","volume":"105","author":"Menaa","year":"2000","journal-title":"J Clin Invest"},{"key":"B55","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1056\/NEJMoa013096","article-title":"Osteoprotegerin deficiency and juvenile Paget\u2019s disease","volume":"347","author":"Whyte","year":"2002","journal-title":"N Engl J Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1902\/jop.2005.76.11-S.2033","article-title":"Immune response: the key to bone resorption in periodontal disease","volume":"76","author":"Taubman","year":"2005","journal-title":"J Periodontol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/1759720X12438080","article-title":"The role of RANK ligand\/osteoprotegerin in rheumatoid arthritis","volume":"4","author":"Geusens","year":"2012","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"B58","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.yjmcc.2003.09.015","article-title":"Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification","volume":"36","author":"Kaden","year":"2004","journal-title":"J Mol Cell Cardiol"},{"key":"B59","first-page":"123","article-title":"Role of RANKL-RANK\/osteoprotegerin pathway in cardiovascular and bone disease associated with HIV infection","volume":"16","author":"Kelesidis","year":"2014","journal-title":"AIDS Rev"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1161\/01.CIR.0000127957.43874.BB","article-title":"Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease","volume":"109","author":"Kiechl","year":"2004","journal-title":"Circulation"},{"key":"B61","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/nrrheum.2012.167","article-title":"New developments in osteoimmunology","volume":"8","author":"Takayanagi","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3389\/fimmu.2014.00511","article-title":"Biology of the RANKL-RANK-OPG system in immunity, bone, and beyond","volume":"5","author":"Walsh","year":"2014","journal-title":"Front Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/ar3323","article-title":"Regulation of bone by the adaptive immune system in arthritis","volume":"13","author":"Okamoto","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1136\/ard.2011.153312","article-title":"Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis","volume":"70","author":"Yeo","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1056\/NEJMoa032534","article-title":"Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis","volume":"350","author":"Edwards","year":"2004","journal-title":"N Engl J Med"},{"key":"B66","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1136\/annrheumdis-2013-204116","article-title":"Expression of FcRL4 defines a pro-inflammatory, RANKL-producing B cell subset in rheumatoid arthritis","volume":"74","author":"Yeo","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B67","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s12026-009-8096-7","article-title":"Insights into the heterogeneity of human B cells: diverse functions, roles in autoimmunity, and use as therapeutic targets","volume":"45","author":"Anolik","year":"2009","journal-title":"Immunol Res"},{"key":"B68","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1136\/annrheumdis-2011-200198","article-title":"Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis","volume":"71","author":"Boumans","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"B69","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1136\/ard.2010.137703","article-title":"Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial","volume":"70","author":"Tak","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B70","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1007\/s10067-017-3747-x","article-title":"Circulating osteoprotegerin levels are elevated in rheumatoid arthritis: a systematic review and meta-analysis","volume":"36","author":"Wang","year":"2017","journal-title":"Clin Rheumatol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"29713","DOI":"10.1038\/srep29713","article-title":"Expression of osteoprotegerin and its ligands, RANKL and TRAIL, in rheumatoid arthritis","volume":"6","author":"Remuzgo-Martinez","year":"2016","journal-title":"Sci Rep"},{"key":"B72","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3899\/jrheum.131037","article-title":"Independent relationship of osteoprotegerin concentrations with endothelial activation and carotid atherosclerosis in patients with severe rheumatoid arthritis","volume":"41","author":"Dessein","year":"2014","journal-title":"J Rheumatol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3899\/jrheum.140690","article-title":"Osteoprotegerin concentrations relate independently to established cardiovascular disease in rheumatoid arthritis","volume":"42","author":"Lopez-Mejias","year":"2015","journal-title":"J Rheumatol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/01.STR.0000129790.00318.a3","article-title":"Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis","volume":"35","author":"Golledge","year":"2004","journal-title":"Stroke"},{"key":"B75","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1084\/jem.192.4.463","article-title":"Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis","volume":"192","author":"Min","year":"2000","journal-title":"J Exp Med"},{"key":"B76","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1016\/j.jacc.2010.03.013","article-title":"Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity","volume":"55","author":"Venuraju","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.amjcard.2006.08.064","article-title":"Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study)","volume":"99","author":"Abedin","year":"2007","journal-title":"Am J Cardiol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1161\/01.ATV.0000039169.47943.EE","article-title":"B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice","volume":"22","author":"Major","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"29851","DOI":"10.1074\/jbc.M112.377945","article-title":"Receptor activator of nuclear factor kappaB ligand (RANKL) protein expression by B lymphocytes contributes to ovariectomy-induced bone loss","volume":"287","author":"Onal","year":"2012","journal-title":"J Biol Chem"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1172\/JCI117424","article-title":"Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow","volume":"94","author":"Masuzawa","year":"1994","journal-title":"J Clin Invest"},{"key":"B81","doi-asserted-by":"publisher","first-page":"9360","DOI":"10.1073\/pnas.94.17.9360","article-title":"Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency","volume":"94","author":"Miyaura","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1002\/jcb.21121","article-title":"Ovariectomy-induced bone loss occurs independently of B cells","volume":"100","author":"Li","year":"2007","journal-title":"J Cell Biochem"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/S0140-6736(05)67728-8","article-title":"Periodontal diseases","volume":"366","author":"Pihlstrom","year":"2005","journal-title":"Lancet"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1902\/jop.2008.080233","article-title":"Inflammation and bone loss in periodontal disease","volume":"79","author":"Cochran","year":"2008","journal-title":"J Periodontol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"625","DOI":"10.4049\/jimmunol.176.1.625","article-title":"Bacterial-responsive B lymphocytes induce periodontal bone resorption","volume":"176","author":"Han","year":"2006","journal-title":"J Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.cyto.2010.02.022","article-title":"B cells as under-appreciated mediators of non-auto-immune inflammatory disease","volume":"50","author":"Nikolajczyk","year":"2010","journal-title":"Cytokine"},{"key":"B87","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1034\/j.1600-051X.2002.290402.x","article-title":"The presence of local and circulating autoreactive B cells in patients with advanced periodontitis","volume":"29","author":"Berglundh","year":"2002","journal-title":"J Clin Periodontol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S1473-3099(15)00056-0","article-title":"Future challenges for clinical care of an ageing population infected with HIV: a modelling study","volume":"15","author":"Smit","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"B89","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1086\/590150","article-title":"Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions","volume":"47","author":"Effros","year":"2008","journal-title":"Clin Infect Dis"},{"key":"B90","first-page":"101","article-title":"Aging, inflammation, and HIV infection","volume":"20","author":"Aberg","year":"2012","journal-title":"Top Antivir Med"},{"key":"B91","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1097\/QAD.0b013e32801022eb","article-title":"Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review","volume":"20","author":"Brown","year":"2006","journal-title":"AIDS"},{"key":"B92","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1210\/jc.2006-2190","article-title":"Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease","volume":"92","author":"Triant","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B93","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nri2524","article-title":"B cells in HIV infection and disease","volume":"9","author":"Moir","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nri1838","article-title":"B-cell targeting in rheumatoid arthritis and other autoimmune diseases","volume":"6","author":"Edwards","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.2741\/2254","article-title":"B cell depletion therapy in autoimmune diseases","volume":"12","author":"Sanz","year":"2007","journal-title":"Front Biosci"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1084\/jem.20072683","article-title":"Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals","volume":"205","author":"Moir","year":"2008","journal-title":"J Exp Med"},{"key":"B97","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1086\/656412","article-title":"Bone disease in HIV infection: a practical review and recommendations for HIV care providers","volume":"51","author":"McComsey","year":"2010","journal-title":"Clin Infect Dis"},{"key":"B98","doi-asserted-by":"publisher","first-page":"13848","DOI":"10.1073\/pnas.1003020107","article-title":"Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats","volume":"107","author":"Vikulina","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B99","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.clim.2003.09.001","article-title":"Regulatory effects of osteoprotegerin on cellular and humoral immune responses","volume":"109","author":"Stolina","year":"2003","journal-title":"Clin Immunol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1359\/jbmr.2001.16.2.348","article-title":"The effect of a single dose of osteoprotegerin in postmenopausal women","volume":"16","author":"Bekker","year":"2001","journal-title":"J Bone Miner Res"},{"key":"B101","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0140-6736(11)61226-9","article-title":"Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial","volume":"379","author":"Smith","year":"2012","journal-title":"Lancet"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1359\/JBMR.040305","article-title":"A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women","volume":"19","author":"Bekker","year":"2004","journal-title":"J Bone Miner Res"},{"key":"B103","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/ar2167","article-title":"Role of RANKL inhibition in osteoporosis","volume":"9","author":"McClung","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"B104","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1056\/NEJMoa044459","article-title":"Denosumab in postmenopausal women with low bone mineral density","volume":"354","author":"McClung","year":"2006","journal-title":"N Engl J Med"},{"key":"B105","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s11912-010-0088-1","article-title":"RANK ligand: effects of inhibition","volume":"12","author":"George","year":"2010","journal-title":"Curr Oncol Rep"},{"key":"B106","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00198-010-1326-y","article-title":"Do RANKL inhibitors (denosumab) affect inflammation and immunity?","volume":"22","author":"Ferrari-Lacraz","year":"2011","journal-title":"Osteoporos Int"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01851\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T00:11:24Z","timestamp":1719706284000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01851\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,22]]},"references-count":106,"alternative-id":["10.3389\/fimmu.2017.01851"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.01851","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,22]]},"article-number":"1851"}}